Fiscal Year Ending November 2026 Third Quarter Financial Summary (Japanese GAAP) (Consolidated)

Overview of Results

During the cumulative third quarter period of the fiscal year ending November 2026, the Group recorded revenue of 52,247 million yen (14.9% increase year-over-year), operating income of 3,009 million yen, ordinary income of 2,799 million yen, and quarterly net income attributable to owners of the parent of 2,006 million yen, securing year-on-year profit growth. By segment, Fine Chemicals, HB C & Food, Pharmaceuticals, and Chemicals contributed, with particularly strong demand in chemicals and surface treatment-related areas driving higher revenue and profit. Supplementary materials are available; the full-year forecast remains revenue 68,000 million yen, operating income 3,400 million yen, and net income 2,350 million yen.

Impact on Shareholders and Outlook

The latest dividend forecast is an annual dividend of 18 yen for the fiscal year ending November 2026, with interim and fiscal dividends of 9 yen each, totaling 18 yen for the year. No earnings briefing was held, but supplementary materials have been released. Going forward, while being exposed to factors such as raw material costs, SG&A trends, and exchange rate fluctuations, the Company expects to maintain growth through expansion of each segment and acquisition of new projects, supported by its medium- to long-term vision and medium-term management plan.